The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Eva M. Lonn

Department of Medicine

McMaster University





Name/email consistency: high



  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada. 2001 - 2009
  • Hamilton Health Sciences Corporation, Hamilton, Ontario. 2006
  • Population Health Research Institute, Hamilton General Hospital, McMaster University, and the Department of Medicine, Ont. 2006
  • Hamilton Health Sciences, General Site, 237 Barton Street East, Hamilton, Canada. 2006
  • Division of Cardiology and Population Health Institute, McMaster University, Hamilton General Hospital, 237 Barton Street East, Canada. 2002 - 2004


  1. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). Lonn, E.M., Gerstein, H.C., Sheridan, P., Smith, S., Diaz, R., Mohan, V., Bosch, J., Yusuf, S., Dagenais, G.R. J. Am. Coll. Cardiol. (2009) [Pubmed]
  2. Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction? Lonn, E. Curr. Opin. Hematol. (2007) [Pubmed]
  3. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Lonn, E., Held, C., Arnold, J.M., Probstfield, J., McQueen, M., Micks, M., Pogue, J., Sheridan, P., Bosch, J., Genest, J., Yusuf, S. Can. J. Cardiol (2006) [Pubmed]
  4. Homocysteine lowering with folic acid and B vitamins in vascular disease. Lonn, E., Yusuf, S., Arnold, M.J., Sheridan, P., Pogue, J., Micks, M., McQueen, M.J., Probstfield, J., Fodor, G., Held, C., Genest, J. N. Engl. J. Med. (2006) [Pubmed]
  5. Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions. Lonn, E., Grewal, J. Curr. Vasc. Pharmacol (2006) [Pubmed]
  6. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial. Lonn, E., Shaikholeslami, R., Yi, Q., Bosch, J., Sullivan, B., Tanser, P., Magi, A., Yusuf, S. J. Am. Coll. Cardiol. (2004) [Pubmed]
  7. The clinical relevance of pharmacological blood pressure lowering mechanisms. Lonn, E. Can. J. Cardiol (2004) [Pubmed]
  8. Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients. Lonn, E., Mathew, J., Pogue, J., Johnstone, D., Danisa, K., Bosch, J., Baird, M., Dagenais, G., Sleight, P., Yusuf, S. Eur. J. Cardiovasc. Prev. Rehabil (2003) [Pubmed]
  9. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis. Lonn, E. Curr. Atheroscler. Rep (2002) [Pubmed]
  10. Effect of long-term therapy with ramipril in high-risk women. Lonn, E., Roccaforte, R., Yi, Q., Dagenais, G., Sleight, P., Bosch, J., Suhan, P., Micks, M., Probstfield, J., Bernstein, V., Yusuf, S. J. Am. Coll. Cardiol. (2002) [Pubmed]
  11. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Lonn, E., Yusuf, S., Hoogwerf, B., Pogue, J., Yi, Q., Zinman, B., Bosch, J., Dagenais, G., Mann, J.F., Gerstein, H.C. Diabetes. Care (2002) [Pubmed]
  12. Dose response of ACE inhibitors: implications of the SECURE trial. Lonn, E. Curr. Control. Trials. Cardiovasc. Med (2001) [Pubmed]
WikiGenes - Universities